1,365 results on '"van Leeuwen, Flora E."'
Search Results
102. Risk of ovarian cancer in women who give birth after assisted reproductive technology (ART)—a registry-based Nordic cohort study with follow-up from first pregnancy
103. Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data
104. Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohort
105. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma
106. Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nation-wide cohort: Implications for clinical and epidemiological studies Authors
107. P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
108. P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
109. P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
110. T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
111. P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment
112. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
113. Long-Term Survivors of Retinoblastoma: Risk of Increased Second Malignancy
114. Second Malignancy Risk After Treatment of Hodgkin Lymphoma
115. Current knowledge and future research directions in treatment-related second primary malignancies
116. Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast
117. Leukemia and brain tumors among children after radiation exposure from CT scans: design and methodological opportunities of the Dutch Pediatric CT Study
118. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
119. Cancer incidence in Dutch Balkan veterans
120. Long-term risk of secondary skin cancers after radiation therapy for Hodgkin’s lymphoma
121. Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors:A Cross-Sectional Study
122. Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors
123. Bradford Hill and breast implant illness: no evidence for causal association with breast implants
124. Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort
125. Dose-Effect Relationships for Adverse Events After Cranial Radiation Therapy in Long-term Childhood Cancer Survivors
126. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
127. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman
128. Questionnaire‐ and linkage‐based outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER study part 1.
129. Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data.
130. Single‐item chronotype is associated with dim light melatonin onset in lymphoma survivors with fatigue
131. Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations
132. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits
133. Cancer risk in DES daughters
134. Reliability of Self-Reported Diagnostic Radiation History in BRCA1/2 Mutation Carriers
135. Effect of Web-Based Versus Paper-Based Questionnaires and Follow-Up Strategies on Participation Rates of Dutch Childhood Cancer Survivors: A Randomized Controlled Trial
136. Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
137. p53 and Neu (c-erbB-2) Overexpression in Relation to Risk Factors for Breast Cancer
138. Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
139. Physical Activity and Breast Cancer: A Systematic Review
140. Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors
141. Silicone Particle Migration: A Misleading Report
142. Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.
143. Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors.
144. Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors.
145. Second Cancer Risk Up to 40 Years after Treatment for Hodgkinʼs Lymphoma
146. Second Malignancy Risk After Treatment of Hodgkin Lymphoma
147. Cardiovascular Morbidity After Radiotherapy or Chemoradiation in Patients With Cervical Cancer
148. Evaluation of Late Adverse Events in Long-Term Wilms' Tumor Survivors
149. Radiation-Associated Breast Tumors Display a Distinct Gene Expression Profile
150. Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.